Haplotype analysis of single nucleotide polymorphisms in anti-Müllerian hormone gene in Chinese PCOS women

Archives of Gynecology and Obstetrics

Volumn 288, Issue 1, 2013, Pages 125-130

  Xu, Pei ^a   Shen, Shan Mei ^a   Zhang, Xin Lin ^a   Liang, Fengjing ^a   Xie, Guang Bin ^a   Yi, Long ^a   Gao, Qian ^a   Wang, Yong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Anti M llerian hormone (AMH); Polycystic ovary syndrome (PCOS); Polymorphism; Tagging SNP

Indexed keywords

LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PROGESTERONE;

ADULT; ANTIMULLERIAN HORMONE GENE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANALYSIS OF VARIANCE; ANTI-MULLERIAN HORMONE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; HAPLOTYPES; HUMANS; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGESTERONE; YOUNG ADULT;

EID: 84879409327     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2734-y     Document Type: Article

References (24)

1. Zhang CW, Zhang XL, Xia YJ, Cao YX, Wang WJ, Xu P et al (2012) Association between polymorphisms of the CYP11A1 gene and polycystic ovary syndrome in Chinese women. Mol Biol Rep 39(8):8379-8385. doi: 10.1007/s11033-012-1688-7
2. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertili Steril 81(1):19-25
3. Azziz RK-MM (2000) Family history as a risk factor for the polycystic ovary syndrome. J Pediatr Endocrinol Metab 13(5):1303-1306
4. Colilla SC, Cox NJ, Ehrmann DA (2001) Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 86(5):2027-2931. doi: 10.1210/jc.86.5.2027 (Pubitemid 32472915)
5. Benítez RS-PT, Palomino A, Angel B, Maliqueo M, Pérez F, Calvillán M (2001) Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome. Rev Med Chil 129(7):707-712
6. Ehrmann DA, Tang X, Yoshiuchi I, Cox NJ, Bell GI (2002) Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87(9):4297-4300
7. Xu P, Che Y, Cao Y, Wu X, Sun H, Liang F, Sun J, Ke L, Yi L, Wang Y (2010) Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome. J Assist Reprod Genet 27(1):23-28. doi: 10.1007/s10815-009-9377- 8
8. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE (1999) Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of sertoli and granulosa cells. J Clin Endocrinol Metab 84(10):3836-3844 (Pubitemid 30645250)
9. Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, Mason H (2007) Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 92(1):240-245. doi: 10.1210/Jc.2006-1582 (Pubitemid 46067538)
10. Durlinger AG, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM et al (2001) Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142(11):4891-4899 (Pubitemid 33022365)
11. Fallat ME, Siow Y, Marra M, Cook C, Carrillo A (1997) Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil Steril 67(5):962-965 (Pubitemid 27183931)
12. Kevenaar ME, Laven JSE, Fong SL, Uitterlinden AG, de Jong FH, Themmen APN, Visser JA (2008) A functional anti-Mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients. J Clin Endocrinol Metab 93(4):1310-1316. doi: 10.1210/jc.2007-2205 (Pubitemid 351519726)
13. Knight PG, Glister C (2006) TGF-beta superfamily members and ovarian follicle development. Reproduction 132(2):191-206. doi: 10.1530/rep.1.01074 (Pubitemid 44274724)
14. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP (2001) Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142(11):4891-4899 (Pubitemid 33022365)
15. Dumesic DA, Lesnick TG, Stassart JP, Ball GD, Wong A, Abbott DH (2009) Intrafollicular antimullerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer. Fertil Steril 92(1):217-221. doi: 10.1016/j.fertnstert.2008.04.047
16. Panidis DFD, Rousso D, Katsikis I, Kourtis A, Diamanti-Kandarakis E (2005) Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome. Fertil Steril 84(2):3. doi: 10.1016/j.fertnstert.2005.02.017 (Pubitemid 41125289)
17. Georgopoulos NA, Saltamavros AD, Decavalas G, Piouka A, Katsikis I, Panidis D (2010) Serum AMH, FSH, and LH levels in PCOS. Fertil Steril 93(3):e13. doi: 10.1016/j.fertnstert.2009.10.006 author reply e14
18. Panidis DKI, Karkanaki A, Piouka A, Armeni AK, Georgopoulos NA (2011) Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels. Med Hypotheses 77(4):5. doi: 10.1016/j.mehy.2011.07.005
19. Piouka A, Farmakiotis D, Macut D, Gerou S, Katsikis I, Panidis D (2009) Anti-Mullerian hormone levels are increased in women with classical PCOS and are negatively influenced by obesity. Am J Endocrinol Metab 296E(E):238-243
20. Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, Mason H (2007) Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 92(1):240-245. doi: 10.1210/jc.2006-1582 (Pubitemid 46067538)
21. Sukalich S, Guzick D (2003) Cardiovascular health in women with polycystic ovary syndrome. Seminars in reproductive medicine 21(3):309-315. doi: 10.1055/s-2003-43309 (Pubitemid 37296803)
22. Loverro G (2004) Polycystic ovary syndrome and cardiovascular disease. Minerva Endocrinol 29(3):129-138
23. Lakhani K, Prelevic GM, Seifalian AM, Atiomo WU, Hardiman P (2004) Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors. J of obstet and gynaecol: the j of the Inst of Obstet and Gynaecol 24(6):613-621. doi: 10.1080/01443610400007810 (Pubitemid 39655416)
24. Vrbikova J, Hainer V (2009) Obesity and polycystic ovary syndrome. Obes facts 2(1):26-35. doi: 10.1159/000194971